Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical...
from PR Newswire: https://ift.tt/2sOpVDc
No comments:
Post a Comment